Optimum treatment of stable angina pectoris

Cardiovascular Drugs and Therapy
W W Parmley

Abstract

From a therapeutic point of view, angina pectoris is best thought of as an imbalance between oxygen supply and demand. Oxygen supply to the heart can be increased by improving endothelial function to increase vasodilation. Non-endothelial-mediated vasodilation will also help increase coronary flow. Coronary vasodilators, such as the calcium blockers and nitrates, are effective agents in relieving vasoconstriction and improving coronary blood flow. Reduction of oxygen demand is accomplished by decreasing heart rate, blood pressure, heart size, and left ventricular mass. Beta-blockers and heart rate-lowering calcium entry blockers are effective in reducing oxygen demand. Additive effects occur by combining a beta-blocker and a dihydropyridine calcium entry blocker. Together with reduction of risk factors, this combination therapy plus aspirin provides optimal management of patients with angina pectoris.

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.